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AbsTrACT
Aims To compare the biomechanically corrected 
intraocular pressure (IOP) estimate (bIOP) provided by 
the Corvis-ST with Goldmann applanation tonometry 
(GAT-IOP) in patients with high-tension and normal-
tension primary open-angle glaucoma (POAG; HTG and 
NTG), ocular hypertension (OHT) and controls. Moreover, 
we compared dynamic corneal response parameters 
(DCRs) of the Corvis-ST in POAG, OHT and controls, 
evaluated the correlation between global visual field 
parameters mean deviation and pattern SD (MD and 
PSD) and DCRs in the POAG group.
Methods 156 eyes of 156 patients were included 
in this prospective, single-centre, observational study, 
namely 41 HTG and 33 NTG, 45 OHT cases and 37 
controls. Central corneal thickness (CCT), GAT-IOP and 
bIOP were measured, GAT-IOP was also adjusted for CCT 
(GATAdj). DCRs provided by Corvis-ST were evaluated, 
MD and PSD were recorded by 24–2 full-threshold visual 
field. To evaluate the difference in DCRs between OHT, 
HTG and NTG, a general linear model was used with sex, 
medications and group as fixed factors and bIOP and 
age as covariates.
results There was a significant difference between 
GAT-IOP, GATAdj and bIOP in NTG and HTG, OHT and 
controls. NTG corneas were significantly softer and more 
deformable compared with controls, OHT and HTG as 
demonstrated by significantly lower values of stiffness 
parameters A1 and highest concavity and higher values 
of inverse concave radius (all p<0.05). There was a 
significant correlation (p<0.05) between MD, PSD and 
many DCRs with POAG patients with softer or more 
compliant corneas more likely to show visual field 
defects.
Conclusions Corneal biomechanics might be a 
significant confounding factor for IOP measurement 
that should be considered in clinical decision-making. 
The abnormality of corneal biomechanics in NTG and 
the significant correlation with visual field parameters 
might suggest a new risk factor for the development or 
progression of NTG.
InTroduCTIon
Glaucoma is a disease characterised by progres-
sive optic neuropathy and visual field loss with 
or without raised intraocular pressure (IOP).1 
Normal-tension glaucoma (NTG) is a form of 
primary open-angle glaucoma (POAG), in which 
IOP remains within normal levels; while high-ten-
sion glaucoma (HTG) is associated with elevated 
IOP. Biomechanical properties of the optic nerve 
head (ONH) and peripapillary scleral connective 
tissue have been postulated to determine how these 
structures respond to IOP, which may account for 
why some patients are susceptible to glaucomatous 
damage even under normal levels of IOP.2 Never-
theless, since the cornea and sclera are continuous 
collagenous sheaths, made up of similar extracel-
lular matrix constituents, an hypothesis could be 
that the biomechanical properties of the cornea 
may be somehow related to those of the lamina 
cribrosa (LC) or peripapillary sclera, which might 
determine the response of the ONH to IOP and the 
amount of axonal nerve damage.3 Assessment of 
corneal biomechanics may, therefore, offer an indi-
rect measurement of the LC elasticity, and hence a 
possible indication of susceptibility to glaucomatous 
damage. However, it must be noted that the prop-
erties of the cornea are not constant from centre 
to periphery and through the sclera to the back of 
the eye. This link has been previously hypothesised 
in certain forms of glaucoma (NTG) which showed 
that abnormal corneal biomechanics was associated 
with progressive visual field loss.4 It is well known 
that the reduction of IOP is neuroprotective, in the 
sense that it delays or even prevents the structural 
and functional damage of optic nerve axons in glau-
coma, including NTG.5–7 For this reason, the accu-
rate measurement of IOP is an essential component 
of glaucoma management including case definition 
and in planning treatment. However, the accuracy 
of IOP measurement is influenced by the biome-
chanical properties of the cornea, of which the most 
important are corneal thickness and material stiff-
ness.8 There have been numerous attempts using 
different devices to introduce an IOP estimate that 
would take into account corneal biomechanics.9–12
The challenge to produce IOP measurements 
with reduced biomechanical effect has also been 
addressed by the non-contact tonometer Corvis-ST 
(Oculus, Wetzlar, Germany) in the form of biome-
chanically corrected IOP (bIOP). The bIOP algo-
rithm was developed using numerical, finite 
element simulations of the Corvis-ST procedure 
applied on human eye models with different topog-
raphies, thickness profiles, material properties and 
IOP values, and was shown to be significantly less 
affected by corneal parameters.13 Recently, the 
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Table 1 Demographics and ocular characteristics for patients with 
ocular hypertension (OHT), primary open-angle glaucoma high-
tension glaucoma (HTG), normal-tension glaucoma (NTG) and healthy 
eye controls, mean±SD
normal oHT HTG nTG P value
No of eyes 37 45 41 33 NA
Eye (right/left) 22/15 25/15 20/16 12/18 0.619
Sex (male/female) 10/27 18/22 20/16 15/15 0.003
CCT (µm) 553±33 547±53 522±31 504±34 <0.001
Age (years) 71.8±10.3 60±12.0 70.9±10.3 75.1±9.5 <0.001
bIOP (mm Hg) 13.4±2.8 17.0±4.1 14.8±3.1 12.9±2.3 <0.001
GAT-IOP (mm Hg) 16.4±2.4 22.1±4.8 17.2±4.9 13.7±1.8 <0.001
GATAdj (mm Hg) 15.3±2.7 20.8±5.5 18.6±4.3 16.3±2.7 <0.001
CCT, central corneal thickness; GATAdj, Goldmann applanation tonometry 
intraocular pressure adjusted for pachymetry; GAT-IOP, Intraocular pressure 
measured by Goldmann applanation tonometry; NA, not applicable; bIOP, 
biomechanically-corrected intraocular pressure estimate provided by the Corvis ST.
bIOP correction has been successful in providing close estimates 
of true IOP in ex vivo tests conducted on human donor eye 
globes, and in reducing association with the cornea’s thickness.14
The aim of this study was to compare the bIOP estimates with 
Goldmann applanation tonometry IOP (GAT-IOP) in patients 
with POAG (HTG and NTG), ocular hypertension (OHT) and 
in healthy controls. Further, we aimed to assess and compare the 
dynamic corneal response parameters (DCRs), provided by the 
Corvis-ST, in the POAG, OHT and control groups, and eval-
uate the correlation between visual field parameters and corneal 
biomechanics in the POAG group.
MATerIAls And MeTHods
Population
Patients diagnosed using the criteria described below with 
(POAG: HTG and NTG), OHT and healthy subjects were 
recruited over a period of 8 months in St Paul’s Eye Unit, 
Royal Liverpool University Hospital, UK. All patients provided 
informed consent for using their anonymised data in the study 
prior to the study commencement.
Inclusion criteria
POAG was defined as open-angle gonioscopy, glaucomatous 
optic disc and an abnormal visual field (VF) consistent with glau-
coma confirmed by at least two reliable VF examinations. The 
definition of glaucomatous visual field defect was defined by two 
glaucoma hemifield tests graded “outside normal limits” and a 
cluster of three contiguous points at the 5% level on the pattern 
deviation plot, using the threshold test strategy with the 24-2 
test pattern of the Zeiss-Humphrey field analyzer. Patients were 
divided into HTG and NTG based on an untreated GAT-IOP 
greater or lower than 21 mm Hg. OHT patients were defined as 
normal VF with an untreated GAT-IOP greater than 21 mm Hg, 
respectively. Healthy controls had an untreated GAT-IOP lower 
than 21 mm Hg, healthy discs and no ocular pathologies.
exclusion criteria
 ► Hypermetropia or myopia >5 diopters (D), and/or astigma-
tism >3 D, best-corrected visual acuity <20/40.
 ► Ocular conditions that could mimic glaucomatous visual field 
loss particularly congenital or acquired optic nerve diseases, 
or systemic conditions that could affect ocular blood flow—
particularly diabetes mellitus and cerebrovascular diseases.
 ► Previous ocular or intraocular surgery or previous trauma or 
corneal scarring.
Ophthalmological examination
All participants underwent initial complete ophthalmic exam-
ination. The OHT and POAG groups also underwent auto-
mated perimetry using Humphrey Field Analyzer II (Carl Zeiss 
Meditec, Jena, Germany), with a full threshold 24–2 SITA 
standard programme. Global visual field parameters, including 
mean deviation (MD) and pattern SD (PSD), were recorded. IOP 
(mean of 3 measurements) and central corneal thickness (CCT) 
(mean of 25 measurements, one touch) were recorded using 
(GAT-IOP, Haag-Streit, Switzerland) and ultrasound pachymetry 
(DGH 55B Pachmate 2, DGH Technologies, Exton, Pennsyl-
vania, USA), respectively, as well as corneal biomechanics and 
IOP measurement using the Corvis-ST. GAT-IOP was adjusted 
for pachymetry (GATAdj) using the manufacturer’s correction 
algorithm provided with the Pachmate 2, which is based on a 
reference corneal thickness of 545 µm from the work of Kohl-
haas et al11
Corvis measurements
All measurements with the Corvis-ST (software V.6.08r22) were 
captured by automatic release on alignment with the corneal 
apex and were all with ‘OK’ quality score. The DCRs used in 
the study are summarised in online supplementary table 115 16 
and were previously described.17 18 We included inverse concave 
radius, stiffness parameters (SP-A1) (referenced at first applana-
tion) and SP-HC (referenced at highest concavity) and deforma-
tion amplitude ratio (DA ratio) as they were shown in earlier 
studies to be well correlated with corneal biomechanics and 
relatively independent of IOP.18 19 Together with DCRs, bIOP 
estimate13 14 was recorded.
statistical analysis
Only one eye per patient (when both eyes could be included) 
was randomly selected and included in the analysis. Statistical 
analyses were performed using the SPSS software (V.24, IBM). 
Sample size calculation was done using G Power V.3.1.9.3 soft-
ware, assuming clinically relevant effect size of 0.4 for the differ-
ence in SP-A1, also suggested by previous unpublished study. 
With four groups, five covariates, alpha of 0.05 and power 
of 0.85, assuming general linear model (GLM) the calculated 
sample size was of minimum 131 subjects. Descriptive statistics 
were calculated for the DCR parameters, as well as GAT-IOP, 
GATAdj and bIOP. Differences between the groups (OHT, 
HTG, NTG and normal) were evaluated with analysis of vari-
ance and Bonferroni post hoc test or logistic regression when 
appropriate. Additionally, to evaluate the difference in corneal 
biomechanics between OHT, HTG and NTG, a GLM was used 
with sex, medications and group as fixed factors and bIOP and 
age as covariates. Medications were defined as four categorical 
variables each having two levels (present/absent). Additionally, 
to exclude CCT as a confounding factor, a subgroup of OHT, 
NTG and HTG patients were matched with CCT (maximum 
difference 8 µm) and by medication (all of them only on pros-
taglandin analogues). A further GLM with SP-A1 as dependent 
variable was performed with group as fixed factor and bIOP and 
age as covariates. The association between the DCR parameters 
and visual field indices such as MD and pattern SD (PSD) was 
expressed with Spearman correlation coefficient. A p<0.05 was 
considered statistically significant.
resulTs
Patient demographics and IOPs are summarised in table 1.
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Table 2 Showing the number and percentage of patients on 
glaucoma medication and mean values±SD of mean deviation (MD) 
and pattern SD (PSD) of patients in the groups of ocular hypertension 
(OHT), high-tensions glaucoma (HTG) and normal-tension glaucoma 
(NTG)
oHT HTG nTG P value
Prostaglandin analogues 31 (58.5%) 37 (78%) 23 (69.7%) 0.260
β-blockers 7 (13.2%) 20 (42.5%) 11 (30.5%) 0.058
CA-inh 5 (9.4%) 17 (36.1%) 10 (27.7%) 0.053
α agonist 3 (5.7%) 4 (8.5%) 1 (2.8%) 0.837
Mean Deviation −1.46±1.90 −7.60±8.45 −6.79±6.28 <0.001
Post hoc p value <0.001 1.000   
Pattern Standard 
Deviation
1.99±1.36 8.40±10.75 6.58±3.88 <0.001
Post hoc p value <0.001 0.199   
P values express the difference between the groups. When applicable post hoc p 
values are between NTG and the other groups.
CA-inh, carbonic anhydrase inhibitors.
Figure 1 Box and whiskers plot for bIOP, Goldmann applanation 
tonometry IOP (GAT) and Goldmann adjusted (GATAdj) in ocular 
hypertension (OHT), primary open-angle glaucoma high-tension 
glaucoma (HTG), normal-tension glaucoma (NTG) and healthy eye 
controls. bIOP, biomechanically corrected intraocular pressure; IOP, 
intraocular pressure.
The mean CCT in NTG was significantly lower than in normal 
(p<0.001) and OHT (p=0.004) groups, but similar to HTG 
(p=1.0). Table 2 shows the number and percentage of patients 
under each type of topical glaucoma medications.
There was no significant difference between the groups (OHT, 
NTG and HTG) in terms of any of the medication, however, 
the p values of carbonic anhydrase inhibitors and beta-blockers 
approached significance (table 2).
Intraocular pressure
Comparative analysis showed a significant difference between 
the values of GAT-IOP, GATAdj and bIOP among the groups and 
within the groups (p<0.001, figure 1).
Within the groups
The main result of this analysis was the significant differ-
ence between the values of GAT-IOP, GATAdj and bIOP in 
all groups (p<0.001). In controls and OHT, the mean values 
of GAT-IOP were significantly higher than GATAdj and bIOP, 
equally GATAdj was significantly higher than bIOP (p<0.01). 
Conversely, GATAdj was significantly higher than GAT-IOP in 
HTG and NTG groups, and GAT-IOP was significantly higher 
than bIOP (p<0.01).
Between the groups
GAT-IOP between the groups
The Bonferroni post hoc tests showed that mean GAT-IOP in 
OHT group was significantly higher than in all other groups 
(p<0.001). Similarly, HTG POAG patients showed higher 
values of GAT-IOP compared with NTG (p=0.003) and lower 
than OHT (p<0.001) but very similar to normal (p=1.00). The 
values of GAT-IOP of OHT were on average 5.6 mm Hg higher 
than controls.
GATAdj-IOP between the groups
The comparative analysis of GATAdj pressure between the 
groups showed that the mean values of OHT and HTG with 
GATAdj were significantly higher compared with controls 
(p<0.001 and p=0.009, table 1).
bIOP between the groups
The results for bIOP showed no difference between the values 
in POAG (HTG and NTG) and control groups but a significant 
difference with OHT. The mean difference between OHT and 
normal was 3.6 mm Hg (p<0.001).
Corneal biomechanics
The analysis of the Corvis DCR parameters, performed with 
GLM which took into account age, sex, bIOP and medication, 
showed a significant difference between at least one group and 
the others in all evaluated parameters (table 3).
The main result of this subanalysis is the evidence that NTG 
corneas are more compliant and deformable under the air puff 
compared with controls, OHT and HTG patients as showed by 
significantly lower values of SP-A1 and HC and significant higher 
values of inverse concave radius and DA ratio (figure 2A–D). 
A subgroup of OHT (11), NTG (11) and HTG (13) patients 
were matched with CCT and by medication (all of them only on 
prostaglandin analogues). The comparative analysis with GLM 
confirmed the previous results, demonstrating that NTG corneas 
are softer and more deformable under the air puff (lower values 
of SP-A1) compared with OHT and HTG patients (p=0.017 
overall, NTG vs OHT p=0.023, NTG vs HTG p=0.007) even 
when matching with CCT.
Visual field and corneal biomechanics
The visual field indices of POAG (HTG and NTG) and OHT 
patients are summarised in table 2. The correlation analysis 
between corneal biomechanics, MD and PSD included only 
POAG patients (HTG and NTG). The main result of this 
subanalysis is the evidence that POAG patients with softer and 
more deformable corneas are significantly more likely to show 
visual field defects than stiffer ones. This was demonstrated by 
a significant negative correlation between MD and DA ratio 
(cc=−0.261 p=0.018), inverse concave radius (cc=−0.242, 
p=0.028) and a significant positive correlation with SP-A1 
(cc=0.279, p=0.011) and SP-HC (cc=0.240, p=0.030).
Similarly, the correlation analysis of corneal biomechanics 
and PSD showed a significant positive correlation with DA 
ratio (cc=0.299, p=0.006), inverse concave radius (cc=0.305, 
p=0.005) and a significant negative correlation with SP-A1 
(cc=−0.346, p=0.001) and SP-HC (cc=−0.329, p=0.003).
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Table 3 Showing mean values±SD of inverse radius, deformation amplitude ratio (DA ratio), stiffness parameter applanation 1 (SP-A1) and SP at 
highest concavity (SP-HC) in ocular hypertension (OHT), high-tensions glaucoma (HTG), normal-tension glaucoma (NTG) and controls
normal oHT HTG nTG overall p value
Inverse radius 8.32±1.02 8.09±2.17 8.54±1.05 9.39±1.01 0.034
Post hoc p value NTG versus other groups 0.016 0.001 0.087   
Post hoc p value HTG versus other groups 0.669 0.049   0.258
DA ratio 1.57±0.05 1.57±0.05 1.61±0.05 1.63±0.04 0.015
Post hoc p value NTG versus other groups 0.057 0.028 1.0000   
Post hoc p value HTG versus other groups 0.242 0.050   0.132
SP-A1 108.5±16.1 117.6±25.4 104.0±18.8 88.1±15.2 <0.001
Post hoc p value NTG versus other <0.0001 <0.0001 0.005   
Post hoc p value HTG versus other 0.234 0.076   0.003
SP-HC 5.73±2.80 8.49±3.43 5.63±3.05 3.17±1.98 0.004
Post hoc p value NTG versus other 0.005 <0.0001 0.010   
Post hoc p value HTG versus other 0.150 0.071   0.017
P values of general linear model. Post hoc p values are between NTG or HTG and the other groups.
Figure 2 (A) Box and whiskers plot for stiffness parameter A1, (B) stiffness parameter highest concavity, (C) inverse concave radius, (D) deformation 
amplitude ratio in ocular hypertension (OHT), primary open-angle glaucoma high-tension glaucoma (HTG), normal-tension glaucoma (NTG) and 
healthy eye controls.
dIsCussIon
Glaucoma is a complex disease and clinically challenging due to 
its multifactorial aetiology.20 Currently, IOP is the only modifi-
able risk factor and the current gold standard for IOP measure-
ment is the Goldmann applanation tonometry (GAT-IOP). 
However, the accuracy of GAT-IOP is influenced by overall 
corneal stiffness which varies with corneal thickness and mate-
rial behaviour.8 The effect of corneal material properties, in 
particular the mechanical stiffness, on GAT-IOP is expected to 
be considerable.8 21
This study aimed to evaluate and compare the bIOP algorithm 
with the GAT-IOP in patients with primary open angle glau-
coma (POAG: NTG and HTG), ocular hypertension (OHT) and 
controls. Subsequently, we aimed to assess and compare corneal 
biomechanics in the described groups and if those biomechanical 
factors were correlated with the visual field defect.
IoP results
The comparative analysis showed a significant difference 
between the values of GAT-IOP, GATAdj and bIOP in POAG 
(HTG and NTG), OHT and controls. In all the groups, bIOP 
was significantly lower than GAT and GATAdj. In previous 
studies, normal subjects mean GAT and bIOP values were very 
similar18 22 and a recent study demonstrated that bIOP equates to 
manometric IOP measurements in ex vivo eyes.14 The difference 
between GAT and bIOP in our study must, therefore, relate to 
the ‘adjusted factors’ that bIOP corrects for, namely, age, CCT 
and corneal biomechanics, or by the higher accuracy and repeat-
ability of Corvis-ST bIOP measurements compared with GAT.23 
As a matter of fact in the study which described the normality 
values of bIOP the mean age was 38±16 years, mean CCT was 
543±33 µm and mean DA ratio was ranging from 1.452 to 
1.727.18 These values are different compared with the normal 
population evaluated in the present study that has a higher age 
and slightly thicker corneas which would cause an overestima-
tion of GAT.
Previous studies showed that GAT-IOP is affected by a margin 
that varied between 0.7 and 7.1 mm Hg per each 100 μm change 
in CCT.24 25 The significance of this error margin should be eval-
uated critically given that the progression risk in patients with 
diagnosed glaucoma is reported to be increased between 10% 
and 12% for each 1 mm Hg increase in IOP,26 and hence the 
consequence of this error could produce significant numbers 
of false-positives and false-negatives in glaucoma risk profiling. 
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Moreover, a previous report showed that differences in corneal 
biomechanics across individuals may have greater impact on 
IOP measurement errors than corneal thickness or curvature.8 
This result underlines the importance of using an IOP estimate 
that is not affected by material properties, age and thickness. 
Furthermore, it should be noted that in controls and OHT, GAT 
was shown to be higher than GATAdj, while in both glaucoma 
groups, it was the opposite. This would suggest that the relative 
differences change with disease, such that the adjustment for 
CCT no longer seems to work. This is consistent with predic-
tions of the work of Liu and Roberts, where stiffer corneas have 
a stronger relationship between CCT and IOP measurement 
error, while in softer corneas, this relationship is diminished.8
In OHT patients, GAT-IOP was on average higher than 21 
mm Hg while bIOP was lower. This result suggests that with the 
use of bIOP, OHT patients (who are patients that, even with high 
IOP did not yet progress to glaucoma) present an IOP that is 
within normal limits (<21 mm Hg) whereas with GAT the IOP is 
higher than the normal range. Previous formulas were proposed 
to improve the management of OHT such as in the OHT treat-
ment study, however, the definition of OHT changed depending 
on which adjustment formula was used.27 Corvis bIOP has many 
advantages when compared with GAT and GATAdj, in partic-
ular it is non-contact, it does not require anaesthesia, it is devel-
oped with numerical modelling and is able to correct for age and 
corneal biomechanics as well as CCT.13
A better estimate of IOP (such as bIOP) could help to separate 
OHT patients at high risk of progression to glaucoma from those 
individuals that are only overestimated by standard tonometers, 
thus improving glaucoma diagnosis and reducing public health 
costs. Further studies are needed to evaluate if bIOP would be 
able to provide a better way to define OHT or follow-up patients 
with glaucoma.
Corneal biomechanics results
The main result of this subanalysis (which took age, bIOP and 
medications into account) is the evidence that NTG corneas are 
softer and more deformable under the air puff compared with 
controls, OHT and HTG. This was demonstrated by signifi-
cantly lower values of SP-A1 and HC and significant higher 
values of inverse concave radius and DA ratio. A softer cornea, in 
general, would be more deformed by the air puff, which will be 
identified by the Corvis with a higher inverse radius of concavity 
and DA ratio. Similarly, it will show lower values of the (SP-A1 
and SP-HC) which are two parameters correlated with overall 
stiffness.28
CCT was purposely not added into the model because it does 
not meet all the criteria of confounding29 and hence would lead 
to a bias. Finally, our last subanalysis which evaluated OHT, 
NTG and HTG patients that were matched with CCT and medi-
cation also confirmed the outcomes of the main analysis and 
excluded the possibility that the results would be driven by the 
difference in CCT.
Based on the evidence that NTGs have corneas that are softer 
and more deformable, the evaluation of corneal biomechanics 
might help in the management/risk stratification of glaucoma-
tous patients.
In the present, the results shown refer to overall stiffness 
(geometrical stiffness and material stiffness together); and show 
that NTGs behave softer compared with other groups. Neverthe-
less, we cannot prove that the material stiffness of NTG patients 
is either softer or stiffer compared with the other groups, more 
studies will be needed, possibly with the use of new indexes not 
influenced by corneal geometry, to evaluate this aspect. Our 
study shows significantly softer corneas (more deformable) in 
NTG patients compared with controls, OHT and HTG with 
new DCRs of the Corvis-ST that are relatively independent 
from IOP.18 Although previous studies focused mainly on HTG 
showed less deformable corneas,30 31 older DCRs known to be 
influenced by IOP were used.18 There is a plethora of studies 
with Ocular Response Analyzer (ORA) in NTG and POAG; 
however, those findings are not directly comparable to the ones 
of the Corvis for two reasons. First, the ORA has a variable 
magnitude air puff, and biomechanical response is dependent on 
load.15 Second, corneal hysteresis is a viscoelastic term and does 
not directly correlate to stiffness. Previous literature found that 
NTG had lower CH compared with POAG and OHT, but this 
cannot be interpreted as either a stiffer or a softer cornea.32 Low 
hysteresis is found in keratoconus with a soft cornea, as well as 
with higher IOP, which is a stiffer cornea.33
Correlation between visual field defect and corneal 
biomechanics
The main finding of this subanalysis is that HTG and NTG 
patients with corneas that are more deformed by the air puff 
(softer) are significantly more likely to show visual field defects 
than those with stiffer corneas (less deformed). These findings 
are partly in agreement (since we did not evaluate progression) 
with previous literature that showed that DCRs are related to 
the progression of HTG34 and NTG.35 As previously mentioned, 
results of the DCRs of the Corvis-ST should not be compared 
with those ORA as not equivalent.
In conclusion, we found a significant difference between 
Goldmann, Goldmann CCT adjusted and bIOP which should 
be related to the compensating factors that bIOP corrects for, 
namely, age, CCT and corneal biomechanics. NTG corneas are 
significantly softer compared with controls, OHT and HTG. 
Patients with glaucoma with more compliant corneas were more 
likely to show visual field defects.
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